- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05684120
Mood Lifters for Undergraduates (ML-UP)
Mood Lifters for Undergraduates Project
Large-scale, effective, low-cost, and evidence-based programs that can nimbly translate new research discoveries into prevention and care for psychosocial-based problems are urgently needed since the vast majority of people who need evidence-based care do not receive it.
The purpose of this randomized control trial is to investigate the feasibility and efficacy of a Mood Lifters group template specifically for undergraduate students. Mood Lifters is an effective peer-led program that improves or maintains mental health. It seeks to help people enhance pleasure, engagement, and meaning in their lives while minimizing depression, fear, loneliness, and other negative feelings via a proprietary peer-based program that offers weekly meetings and other flexible support options. One obstacle to providing mental health care in the US is that it is costly to provide one-on-one therapy by a licensed professional. This is particularly true in large group settings with limited resources (counseling centers) and a large need for mental health care, like universities.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Elena L Pokowitz, M.Ed.
- Phone Number: 919-948-0362
- Email: moodliftersundergrad@umich.edu
Study Contact Backup
- Name: Patricia J Deldin, Ph.D.
- Email: pjdeldin@umich.edu
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48103
- Recruiting
- University of Michigan
-
Contact:
- Patricia Deldin, Ph.D.
- Phone Number: 734-647-7550
- Email: pjdeldin@umich.edu
-
Contact:
- Sandra Graham-Bermann, Ph.D.
- Email: sandragb@umich.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion:
- undergraduate students
- at least 18 years of age
Exclusion criteria include:
- active suicidal thoughts or behavior
- active psychosis
- borderline personality disorder
- active mania
- unwillingness to attend all sessions or treatment types (e.g., unwillingness to attend remote)
- non-undergraduate students.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment Group
Individuals in this arm will take part in the Mood Lifters program immediately after recruitment.
|
Participants will need to attend 14 hour-long virtual weekly meetings on Zoom that focus on helpful mental health strategies and skills.
Participants will be encourage to practice what they learn at home in order to improve their mood or mental wellness.
Other Names:
|
No Intervention: Waitlist Control Group
Individuals in this arm will be invited to take part in the Mood Lifters program after they complete post-treatment surveys as part of the control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Health Questionnaire - 9
Time Frame: through study completion, an average of 1 year
|
Assesses Depressive Symptoms (Range 0-27; higher scores indicate more significant symptoms of depression)
|
through study completion, an average of 1 year
|
Generalized Anxiety Disorder - 7
Time Frame: through study completion, an average of 1 year
|
Assesses Anxiety Symptoms (Range 0-21; higher scores indicate more significant symptoms of anxiety)
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Elena L Pokowitz, M.Ed., University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00221612
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Mood Lifters for Undergraduates
-
University of MichiganCompletedDepression | Mood Disorders | Anxiety Disorders | Stress | Mental IllnessUnited States
-
HucircadianPusan National University Hospital; Korea University Guro Hospital; Korea University... and other collaboratorsRecruitingMajor Depressive Disorder | Bipolar 1 Disorder | Bipolar II DisorderKorea, Republic of
-
Northwell HealthNational Institute on Aging (NIA)Not yet recruitingType 2 DiabetesUnited States
-
The University of Hong KongRecruitingQuality of Life | Insomnia | Depression, AnxietyHong Kong
-
University of California, San DiegoCompletedBipolar DisorderUnited States
-
Butler HospitalNational Institute on Drug Abuse (NIDA)Completed
-
CES UniversityInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) and other collaboratorsUnknown
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedSevere Mood DysregulationUnited States
-
Centre for Addiction and Mental HealthUnknownMood Disorders
-
University of MichiganCompletedDepression | Bipolar DisorderUnited States